CRDF vs V · rev $145.0K vs P/E 33, rev $40.00B
Cardiff Oncology Inc (CRDF) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan M. McInerney.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
CRDF currently screens at market cap $238.8M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the CRDF and V stock pages for the full models.
Not investment advice.